Abstract
Many preclinical studies have shown RNA interference (RNAi) as a new promising way to treat various human diseases including cancer and virus infection and there is an increasing demand for the large-scale preparation of short interfering RNAs (siRNAs) at low cost. Data are accumulating to show that endoribonuclease-prepared siRNAs (esiRNAs) are superior to chemically synthesized siRNAs in terms of expense, efficiency, and specificity. Yet all procedures available for esiRNA purification were designed to produce small amount of siRNAs for laboratory use. In this article, a new method of purification of esiRNAs based on ion exchange chromatography and size exclusion chromatography is reported. The esiRNAs prepared with this method are shown here to be of high purity and specifically suppress homologous gene expression without activating interferon response and with higher efficiency than chemically synthesized siRNAs. We can expect that the new method can be scaled up easily to provide large quantities of esiRNAs to meet the requirement of preclinical and clinical studies.
Similar content being viewed by others
References
Dykxhoorn, D. M., Novina, C. D., and Sharp, P. A. (2003) Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4, 457–467.
Campbell, T. N. and Choy, F. Y. (2005) RNA interference: past, present and future. Curr. Issues Mol. Biol. 7, 1–6.
Wadhwa, R., Kaul, S. C., Miyagishi, M., and Taira, K. (2004) Know-how of RNA interference and its applications in research and therapy. Mutat. Res. 567, 71–84.
Hannon, G. J. and Rossi, J. J. (2004) Unlocking the potential of the human genome with RNA interference. Nature 431, 371–378.
Dillon, C. P., Sandy, P., Nencioni, A., Kissler, S., Rubinson, D. A., and Van Parijs, L. (2005) RNAi as an experimental and therapeutic tool to study and regulate physiological and disease processes. Annu. Rev. Physiol. 67, 147–173.
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811.
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498.
Williams, B. R. (1997) Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans. 25, 509–513.
Caplen, N. J., Parrish, S., Imani, F., Fire, A., and Morgan, R. A. (2001) Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98, 9742–9747.
Yang, D., Goga, A., and Bishop, J. M. (2004) RNA interference (RNAi) with RNase III-prepared siRNAs. Methods Mol. Biol. 252, 471–482.
Kittler, R., Putz, G., Pelletier, L., et al. (2004) An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature 432, 1036–1040.
Qian, Z. K., Xuan, B. Q., Min, T. S., Xu, J. F., Li, L., and Huang, W. D. (2005) A cost-effective method of siRNA preparation and its application to inhibit hepatitis B virus replication in HepG2 cells. World J. Gastroenterol. 11, 1297–1302.
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51–59.
Giladi, H., Ketzinel-Gilad, M., Rivkin, L., Felig, Y., Nussbaum, O., and Galun, E. (2003) Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 8, 769–776.
Ichim, T. E., Li, M., Qian, H., et al. (2004) RNA interference: a potent tool for gene-specific therapeutics. Am. J. Transplant 4, 1227–1236.
Fuchs, U., Damm-Welk, C., and Borkhardt, A. (2004) Silencing of disease-related genes by small interfering RNAs. Curr. Mol. Med. 4, 507–517.
Beal, J. (2005) Silence is golden: can RNA interference therapeutics deliver? Drug Discov. Today 10, 169–172.
Jackson, A. L. and Linsley, P. S. (2004) Noise amidst the silence: off-target effects of siRNAs? Trends Genet. 20, 521–524.
Jackson, A. L., Bartz, S. R., Schelter, J., et al. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21, 635–637.
Snove, O. Jr. and Holen, T. (2004) Many commonly used siRNAs risk off-target activity. Biochem. Biophys. Res. Commun. 319, 256–263.
Scacheri, P. C., Rozenblatt-Rosen, O., Caplen, N. J., et al. (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. USA 101, 1892–1897.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xuan, B., Qian, Z., Tan, C. et al. esiRNAs purified with chromatography suppress homologous gene expression with high efficiency and specificity. Mol Biotechnol 31, 203–209 (2005). https://doi.org/10.1385/MB:31:3:203
Issue Date:
DOI: https://doi.org/10.1385/MB:31:3:203